Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Lilly has reported strong Phase 3 results, including 28.3% average weight loss over 80 weeks at the highest studied dose in one obesity trial, but the drug still requires regulatory review
doi:10.1016/j.oret.2020.08.004 30
For diabetic patients Patients with diabetes are often encouraged to lose weight
This question is being studied, and so far the answers are mixed
In trials, average results were strong, but people did not all lose the same amount of weight or get the same level of glucose improvement
The results of GLP-1 medicines are significant and can help with an incredible amount of weight loss
US$ 24.89
US$ 24.61
US$ 23.88
US$ 21.36
US$ 28.81
US$ 23.47
